United States (US) Bronchopulmonary Dysplasia Market (2025-2031) | Segmentation, Trends, Value, Companies, Analysis, Growth, Outlook, Forecast, Competitive Landscape, Industry, Size & Revenue, Share

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Bronchopulmonary Dysplasia Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Bronchopulmonary Dysplasia Market - Industry Life Cycle

3.4 United States (US) Bronchopulmonary Dysplasia Market - Porter's Five Forces

3.5 United States (US) Bronchopulmonary Dysplasia Market Revenues & Volume Share, By Drugs, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of bronchopulmonary dysplasia in premature infants

4.2.2 Advances in medical technology and treatment options for bronchopulmonary dysplasia

4.2.3 Growing awareness and focus on respiratory health in neonatal care

4.3 Market Restraints

4.3.1 High cost associated with the treatment and management of bronchopulmonary dysplasia

4.3.2 Stringent regulatory requirements for approval of new treatments

4.3.3 Limited availability of specialized healthcare professionals in the field of neonatology

6.1 United States (US) Bronchopulmonary Dysplasia Market, By Drugs

6.1.1 Overview and Analysis

6.1.2 United States (US) Bronchopulmonary Dysplasia Market Revenues & Volume, By Drugs, 2021- 2031F

6.1.3 United States (US) Bronchopulmonary Dysplasia Market Revenues & Volume, By Pneumostem, 2021- 2031F

6.1.4 United States (US) Bronchopulmonary Dysplasia Market Revenues & Volume, By UMC 119 01, 2021- 2031F

6.1.5 United States (US) Bronchopulmonary Dysplasia Market Revenues & Volume, By AT 100, 2021- 2031F

6.1.6 United States (US) Bronchopulmonary Dysplasia Market Revenues & Volume, By OHB-607, 2021- 2031F

7.1 United States (US) Bronchopulmonary Dysplasia Market Export to Major Countries

7.2 United States (US) Bronchopulmonary Dysplasia Market Imports from Major Countries

8.1 Number of neonatal intensive care unit (NICU) admissions for bronchopulmonary dysplasia

8.2 Percentage of premature infants diagnosed with bronchopulmonary dysplasia

8.3 Average length of hospital stay for infants with bronchopulmonary dysplasia

9.1 United States (US) Bronchopulmonary Dysplasia Market Opportunity Assessment, By Drugs, 2021 & 2031F

10.1 United States (US) Bronchopulmonary Dysplasia Market Revenue Share, By Companies, 2024

10.2 United States (US) Bronchopulmonary Dysplasia Market Competitive Benchmarking, By Operating and Technical Parameters